Laraway Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Laraway Financial Advisors's PFE Position: Q1 2026 in Review
Laraway Financial Advisors reduced its Pfizer (PFE) stake by 27% in Q1 2026, selling an estimated $69.2K and leaving 7,159 shares worth $201K. The position accounts for 0.14% of the portfolio, ranked #124.
Laraway Financial Advisors first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $650K in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Laraway Financial Advisors held 7,159 shares of Pfizer worth $201K as of Q1 2026.
- Laraway Financial Advisors sold 2,600 Pfizer shares in Q1 2026, an estimated $69.2K.
- Pfizer made up 0.14% of Laraway Financial Advisors's portfolio in Q1 2026, its #124 holding.
- Laraway Financial Advisors first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- Laraway Financial Advisors's Pfizer position peaked at $650K in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Laraway Financial Advisors's 13F filing for Q1 2026, filed 14 May 2026.